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Disseminated tumor cells in the bone marrow environment are the main cause of sys-
temic metastasis after curative treatment for major solid tumors. However, the detailed 
biological processes of tumor biology in bone marrow have not been well defined in 
a real-time manner, because of a lack of a proper in vivo experimental model thereof. 
In this study, we established intravital imaging models of the bone marrow environ-
ment to enable real-time observation of cancer cells in the bone marrow. Using these 
novel imaging models of intact bone marrow and transplanted bone marrow of mice, 
respectively, via two-photon microscopy, we could first successfully track and analyze 
both the distribution and the phenotype of cancer cells in bone marrow of live mouse. 
Therefore, these novel in vivo imaging models for the bone marrow would provide a 
valuable tool to identify the biologic processes of cancer cells in a real-time manner in 
a live animal model.
Keywords: two-photon microscopy, intravital imaging, bone marrow microenvironment, tumor cell dormancy, 
cancer cell
inTrODUcTiOn
Early systemic metastasis is a major feature of major cancers even after margin-negative resection 
of a primary cancer lesion (1, 2). Circulating tumor cells derived from primary cancer lesion can be 
disseminated to secondary organs including bone marrow blood, lymph node, and distant organ via 
blood vessels or lymphatic channels and can cause early systemic recurrence regardless of definite 
treatment (3, 4). The majority of cancer-related deaths are due to the involvement of metastatic 
tumors originating from disseminated cancer cells (5, 6). Contrary to other malignancies showing 
a dormant tumor phenotype in secondary organs, most notably in breast cancer, it has been known 
that aggressive cancer types such as pancreatic cancer can overcome easily or bypass suppressive 
microenvironment compared to other malignancies having a relatively long dormant period (3, 7–9). 
Therefore, the mechanism of an awakening or activation of cancer cells in secondary organs should 
be investigated in order to prevent early systemic metastasis even in resectable cancer. The tumor 
biology of cancer cells in the bone marrow environment, the main site of minimal residual disease 
after curative cancer treatment, should be investigated in order to identify the specific process of 
systemic metastasis in most solid cancers (3, 10, 11). However, the lack of an in vivo experimental 
model for cancer cells in the bone marrow environment has been a major barrier to exploring the 
initial process of systemic metastasis (4, 12, 13). The aim of this study is to establish intravital imaging 
model of cancer cells in the bone marrow environment.
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MaTerials anD MeThODs
cancer cell lines and culture conditions
Human cancer cell lines MCF7 and AsPC-1 were obtained from 
the American Tissue Culture Collection (ATCC) and grown in 
RPMI-1640 medium (ThermoFisher, Waltham, MA, USA) sup-
plemented with 10% fetal bovine serum, 100  U/ml penicillin, 
and 100 µg/ml streptomycin. These cell lines were authenticated 
by standard short tandem repeat DNA typing methodology 
before purchase from the ATCC. Mouse cancer cell lines 4T1, 
MMT060562, SL4, Lewis Lung Carcinoma, and Pan02 were 
provided by Anticancer Inc. (San Diego, CA, USA). All cell lines 
were maintained and incubated in a humidified CO2 chamber 
maintaining 37°C and 5% CO2.
establishment of Fluorescent cancer  
cell lines
Cancer cell lines were tagged with green or red fluorescent pro-
tein (GFP or RFP) using a lentiviral transduction system. GFP 
and RFP were cloned into pLenti CMV/TO Puro empty vectors 
purchased from Addgene (Cambridge, MA, USA). Lentiviruses 
were prepared by cotransfection of packaging vectors pMD2G, 
pMDLg/pRRE, and pRSV-Rev, and pLenti CMV/TO Puro-GFP 
or RFP into HEK 293T cells. GFP or RFP cancer cell lines were 
established by lentiviral infection using transduction technique, 
and selection was performed for 1–2  weeks using 1  µg/ml of 
puromycin.
Proliferation assay for cancer cells
Assays for the proliferation of cancer cells in the bone marrow 
environment were performed by measuring fluorescence intensity 
every day. Fluorescence intensity was measured using a fluorescence 
microplate reader (Varioskan Flash Multimode Reader, Thermo 
Scientific, USA) using bottom optic readings. Excitation/emission 
wavelengths were 488/507 nm for GFP and 553/574 nm for RFP.
Western Blot analysis
Cells were trypsinized and lysed with a Pro-Prep protein 
extraction kit (iNtRON Biotechnology, Seongnam, Korea). 
Equal amounts of protein extracts (20  µg) were separated by 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis and 
transferred to a nitrocellulose membrane (Invitrogen). Blots 
were blocked with 5% nonfat dry milk at room temperature. The 
blots were incubated with antibodies for ERK1/2 (sc-93, Santa 
Cruz Biotechnology, 1:5,000), phospho-ERK1/2 (sc-101760, 
Santa Cruz Biotechnology, 1:1,000), p38 (sc-7972, Santa Cruz 
Biotechnology, 1:1,000), and phospho-p38 (sc-7973, Santa Cruz 
Biotechnology, 1:500), followed by incubation with peroxidase-
labeled secondary antibodies. Immunoreactive proteins were 
visualized using an enhanced chemiluminescence detection kit 
(Santa Cruz Biotechnology). Blot images were captured using 
an ImageQuant LAS 4000 biomolecular imager (GE Healthcare 
Life Sciences). Quantification of Western blots was conducted 
by ImageJ (Image Processing and Analysis in Java, NIH, USA) 
software. After preparation of the blot images following digital 
scanning, defining regions of interest (ROI) and measurements 
for each ROI were performed consecutively.
animals
C57BL/6 and BALB/c nude mice were purchased from the 
Jackson Laboratory (ME, USA) via Orient Bio (Sungnam, 
Korea). CX3CR1-GFP (14) and LysM-GFP (15) transgenic mice 
were obtained, and genotyping for each strain was performed 
according to the corresponding reference. All mice were main-
tained in a pathogen-free environment in the animal facility at 
Avison Biomedical Research Center in Yonsei University College 
of Medicine, and the animal experiments were approved by the 
Institutional Animal Care and Use Committees at the Yonsei 
University College of Medicine.
Mouse imaging Models for Two-Photon 
intravital imaging
To observe the bone marrow environment effectively, we estab-
lished two imaging window models, a calvarial window in the 
skull and a dorsally transplanted femur bone marrow window. 
A natural imaging window for calvarial bone marrow in skull 
bone had been previously established. Meanwhile, however, 
the dorsally transplanted femur bone marrow model was newly 
created to investigate the exact biology of cancer cells in bone 
marrow. Whole surgical procedures were performed carefully by 
a single hepatobiliary surgeon who has abundant experience in 
microsurgery. The operative procedures for each intravital imag-
ing model were performed as described in the following sections.
establishment of the imaging Window  
for calvarial Bone Marrow
After anesthesia of fluorescence expressing mice (CXCR1-GFP or 
LysM-GFP mouse) using Zoletil® (Virbac Korea, Seoul, Korea) 
via intraperitoneal injection, mice was placed onto a stereotactic 
heating plate (Live Cell Instrument, Seoul, Korea) to maintain 
body temperature. The scalp was removed with scissors with a 
1.5-cm radius (Figure S1A in Supplementary Material), and then, 
acrylic resin was applied around the exposed skull area (Figure 
S1B in Supplementary Material). The fixation ring was attached 
to the pre-applied acrylic resin and then assembled with a stereo-
tactic head fixation device (Live Cell Instrument, Seoul, Korea) 
attached to the heating plate (Figure S1C in Supplementary 
Material).
Preparation of Donor Mouse and 
Processing of Femur Bone graft
After harvesting cultured cancer cells in vitro using a 100-mm dish, 
1-ml syringes with a 31-G needle were prepared with 0.5  ml of 
injectable normal saline mixed with a predefined number of cancer 
cells. The cancer cells were injected into the tail vein of a donor 
mouse (fluorescence expressing mouse: CX3CR1-GFP or LysM-
GFP mouse) for femur bone transplantation with a prefilled 1-ml 
syringe without anesthesia. After a period of mouse breeding in an 
animal facility for mice over 1–7 days after the injection, the femur 
bone of the donor mouse was harvested carefully after euthanasia 
in a CO2 chamber (Figure 1A). The extracted femur bone of the 
donor mouse was immediately processed for long bone transplan-
tation. First, both epiphyses of the femur bone were excised using 
a surgical scalpel blade (No.10) and one side of the femur bone cortex 
FigUre 1 | Establishment of a dorsally transplanted bone marrow model for intravital imaging and application of intravital imaging for cancer cells in the bone 
marrow environment. (a) Schematic presentation of the dorsally transplanted femur bone marrow imaging model using donor and recipient mice (detailed 
procedures for the formation of imaging window and the preparation for intravital imaging were described in Section “Materials and Methods”). (B) Cell viability of 
dorsally transplanted femur bone marrow was confirmed via 4D live imaging tracking, and vascular connections between the donor bone marrow and recipient 
fascia layer were identified by 3D structural analysis (scale bar = 30 µm and see Videos S1 and S2 in Supplementary Material). (c) GFP-expressing monocytes and 
macrophages in bone marrow and RFP expressing cancer cells (MCF7-RFP) (dotted line: blood vessels, scale bar = 50 µm and see Video S3 in Supplementary 
Material). (D) Cancer cells (MCF7-RFP) were located at perivascular areas and distances of cancer cell migration in bone marrow were significantly lower than those 
of macrophages in the Mann–Whitney U test (migration length; MCF7-RFP vs. Resident macrophage = 0.21 ± 0.18 vs. 1.24 ± 0.67 µm, MCF7-RFP vs. patrolling 
macrophage = 0.21 ± 0.18 vs. 7.21 ± 2.14 µm, *p < 0.05). Data were averaged from independently repeated experiments three times. (e) Rarely observed active 
cancer cells in the bone marrow environment (scale bar = 30 µm and see Videos S4 and S5 in Supplementary Material). Pan02-CMPTX; red-labeled Pan02 cells. 
(F) Serial tracking of an active cancer cell (Pan02-CMPTX) in the bone marrow environment.
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was removed with fine micro-dissecting spring scissors (JD-S-16, 
Jeung Do Bio and Plant Co., Ltd., Seoul, Korea) longitudinally. 
Approximately 40% of the circumference of the femur bone shaft 
was removed carefully. To minimize the iatrogenic damage of 
exposed sections of femur bone marrow, the procedure of bone 
opening was carefully performed under a magnifying glass 
(5× magnification, 100 mm diameter convex lens) with moisturiz-
ing with phosphate-buffered saline (PBS) (GIBCO, Thermo Fisher 
Scientific, USA) (Figures S2A,B in Supplementary Material).
establishment of the imaging Window  
for Transplanted Femur Bone Marrow  
in recipient Mice
During the femur bone preparation in the donor mouse, forma-
tion of the imaging window for the dorsal chamber in recipient 
mice (C57BL/6 or BALB/c nude mice) was simultaneously carried 
out in keeping with the progress of femur bone harvesting and 
processing in donor mouse. Recipient mice were anesthetized 
4Lee et al. Real-Time Cancer Cell Monitoring
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by Zoletil® injection into the intraperitoneal cavity and placed 
on a heating plate to maintain body temperature. For stable 
installation of a dorsal chamber kit (SM100, 27  mm titanium, 
APJ trading, USA), the back skin was sutured and retracted in 
an upward direction. The unilateral back skin with round shape 
was removed by fine micro-dissecting spring scissors along the 
position for the microscope cover glass (GL100, 12 mm, 0.13 mm 
thick, APJ trading, USA) for intravital imaging (Figure S2C in 
Supplementary Material). The dorsal chamber kit was assembled 
into the retracted back skin of recipient mice, except for cover 
glass equipment. Immediately after completing femur bone 
processing of the donor mouse, the exposed bone marrow side of 
the femur graft was placed onto the back skin of a recipient mouse 
after being excised in a round shape for cover glass positioning. 
After delicate dropping of PBS around the femur bone graft, the 
cover glass was placed and fixed to the dorsal chamber (Figures 
S2B,C in Supplementary Material).
Two-Photon intravital Microscopy
Mice were anesthetized using via intraperitoneal injection of 
Zoletil at a dose of 30 mg/kg during imaging procedures. Long-term 
anesthesia was performed using the inhalation agent isoflurane. 
A staging system (manual XY stage and microscope mounting 
plate) was set up using Live Cell Instrument Korea (Seoul, Korea), 
and two-photon microscopy (LSM7MP, Carl-Zeiss, Germany) 
was used for imaging data generation. Zen software (Carl-Zeiss) 
was used for image acquisition and basic image analysis. For 
two-photon excitation, light of 880–900 nm wavelength was used 
for imaging green, red, and second harmonic generation. Images 
were acquired at a resolution of 512 × 512 pixels using step sizes 
of 1 µm to a depth of 30–50 µm every 30–60 s.
imaging Data analysis
Fiji/ImageJ software was used for image analysis and basic image 
processing. IMARIS version 7 (Bitplane, USA) and Volocity 
software (PerkinElmer, USA) were used for 3D and 4D imaging 
data analysis.
Flow cytometry analysis
Chronological flow cytometry analysis at baseline (control) 
and 1 and 7  days after cancer cell injection via the tail vein. 
Injectable saline without cancer cells was injected to control 
mice. The acquisition of bone marrow for flow cytometry was 
performed by aspiration from bone marrow of the femur bone 
at the day of injection (control) and 1 and 7 days after injection 
via the tail vein. Then, mouse bone marrow was obtained 1 and 
7 days after cancer cell injection. Harvested bone marrow cells 
were washed with PBS and fixed with 4% paraformaldehyde for 
10 min. The fixed cells were chilled on ice and permeabilized with 
90% methanol for 30 min. Then, 1 × 106 cells per experimental 
condition were aliquoted, washed, and resuspended in 100-µl 
solutions of fluorochrome-conjugated primary antibodies against 
DAPI (564907, BD Biosciences, USA), MHC class II (550750, BD 
Biosciences, USA), and CD11b (553311, BD Biosciences, USA) at 
the manufacturer’s recommended concentrations, and incubated 
for 1  h. For isotype control, fluorochrome-conjugated rabbit 
IgG was used at the same concentration. Cells were washed, 
resuspended in PBS, sorted by fluorescence, and analyzed using 
a FACSAria cell sorter.
statistical analysis
Graphical data generation and basic statistical analyses were 
performed using GraphPad Prism 6 software. Comparisons between 
the separate groups were conducted using the Mann–Whitney 
U test for non-parametric test of continuous variables to calculate 
statistical probability of non-parametric test. p-Values less than 
0.05 were considered statistically significant.
resUlTs anD DiscUssiOn
To monitor the entire biological process of the cancer cells in the 
bone marrow in real-time manner, we established two different 
intravital imaging models to track cancer cells in the bone mar-
row environment of live mice by employing specific windows for 
the calvarium and transplanted femur, respectively. An imaging 
window for indigenous calvarial bone marrow in the mouse skull 
(Figure S1 in Supplementary Material) was adopted with a stable 
fixed-staging system (16). In addition, a novel imaging window 
to observe bone marrow in a transplanted femur was contrived 
using a dorsal chamber (17) (Figure 1A). To investigate whether 
our newly designed femur bone transplantation model works for 
engraftment, we transplanted MCF7-RFP cells injected bone to 
healthy LysM-GFP mice. Using two-photon intravital microscopy 
of the MCF7-RFP-carrying bone marrow transplanted LysM-GFP 
mice, we confirmed that the transplanted femur bone marrow 
was successfully engrafted as a viable live tissue after 7 days from 
the implantation, and intact vascular connections with a vascular 
network system were formed at the fascia layer of the recipient 
mouse (Figure 1B; Videos S1 and S2 in Supplementary Material). 
The transplanted bone marrow tissue was viable at all-time points 
at days 1–30 after the surgery. Therefore, it was feasible to perform 
intravital imaging of the interaction of cancer cell with leukocytes 
from the implanted bone marrow in the recipient mice.
Interestingly, we found that cancer cells were mainly located 
in the perivascular area in the bone marrow environment after 
intravenous injection of cancer cell lines. A total of 5 × 105 of 
cancer cells from human (MCF7 and AsPC-1) and mouse (4T1, 
MMT060562, SL4, Lewis Lung Carcinoma, and Pan02) cancer 
cell lines were used. From 4D image analyses (3-dimensional 
image analyses in time lapse manner), the migration trajectory of 
cancer cells was significantly shorter than those of primary cells 
in the bone marrow environment. The relative location of cancer 
cells from the blood vessel was closer to blood vessel. Migration 
length of cancer cells in an hour was statistically shorter than 
the patrolling macrophage crawling around the vessel wall 
and resident macrophage in the bone marrow parenchyma of 
CX3CR1-GFP mice (Figures 1C,D; Video S3 in Supplementary 
Material). We also confirmed similar localization and migra-
tion pattern of other cancer cells closer to blood vessels, when 
other cancer cells from human (AsPC-1) and mouse (4T1, 
MMT060562, SL4, Lewis Lung Carcinoma, and Pan02) cancer 
cell lines were used for the same experiment (data not shown). 
When we used red-labeled Pan02 cells (Pan02-CMPTX) to 
FigUre 2 | Application of intravital imaging for cancer cells in the bone marrow environment. (a) Engulfment of cancer cells by macrophages (white arrow) in 
calvarial bone marrow imaging (scale bar = 50 μm and see Video S6 in Supplementary Material). (B) Temporal changes in interactions between MCF7-RFP and 
LysM-GFP or CX3CR1-GFP cells in the calvarial bone marrow environment. Contact frequency of MCF7-RFP cells with LysM-GFP or CX3CR1-GFP cells was 
significantly decreased at 24 h compared to 1 h after MCF7-RFP injection via mouse tail vein. The Mann–Whitney U test was used to compare two groups. 
*p < 0.05. Data were averaged from independently repeated experiments three times. (c) Captured bone marrow images in 1, 24, and 144 h (white arrow: clustered 
proliferation of MCF7-RFP) after gemcitabine injection intravenously (scale bar = 50 µm and see Videos S7–S9 in Supplementary Material) in the calvarial bone 
marrow model. (D) Viable cell counts of CX3CR1-GFP and MCF7-RFP (viable cells in 1 h; 84.54 ± 7.81% of CX3CR1-GFP vs. 8.29 ± 7.64% of MCF7-RFP, 24 h; 
73.24 ± 7.64% of CX3CR1-GFP vs. 7.82 ± 7.24% of MCF7-RFP, **p < 0.01) and temporal changes in migration pattern after gemcitabine injection in the calvarial 
bone marrow model (migration length in 1 h; 14.98 ± 2.56 µm in CX3CR1-GFP vs. 1.22 ± 0.84 µm in MCF7-RFP, 24 h; 14.92 ± 3.84 µm in CX3CR1-GRP vs. 
0.94 ± 0.28 µm in MCF7-RFP, **p < 0.01). The Mann–Whitney U test was used to compare two groups. A representative data were shown from independently 
repeated experiments three times. (e) Chronological flow cytometry analysis showing control and 1 and 7 days after cancer cell injection via the tail vein in a mouse 
that was not used for intravital imaging. Injectable saline without cancer cells was injected to control mice. The acquisition of bone marrow for flow cytometry was 
performed by the aspiration from bone marrow of the femur at the day of injection (control) and 1 and 7 days after the injection via tail vein. MHC IIhigh cells and MHC 
IIlowCD11b+Ly6ChiLy6G− cells were significantly increased in day 7. The Mann–Whitney U test was used to compare two groups (cell count of MHC IIhigh; 
39.24 ± 8.84% in control vs. 67.26 ± 12.45% in day 7, MHC IIlowCD11b+Ly6ChiLy6G−; 35.45 ± 8.74% in day 1 vs. 53.48 ± 17.31% in day 7, *p < 0.05). Data were 
averaged from independently repeated experiments three times (see Figure S5 in Supplementary Material). (F) Qualitative analysis of relative fluorescence of 
MCF7-RFP with or without GM-CSF injection before injection and 1, 4 days after injection in dorsally transplanted bone marrow model.
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further compare migration patterns, the phenotypes of cancer 
cells were very quiescent compared to other bone marrow 
components; therefore, once cancer cells extravasated through 
the vasculature, they appeared to simply remain close to the 
outside of the vessel wall. Proliferation assays (Figures S3A–C in 
Supplementary Material) and in vitro live cell imaging (Figures 
S3D,E and Videos S4–S6 in Supplementary Material) revealed 
that the growth rate of cancer cells cocultured with bone marrow 
cells remarkably decreased compared to those of cancer cells 
alone or those cocultured with NIH-3T3 cells (mouse-derived 
fibroblasts). In addition, low ERK/p38 ratios and expression pat-
terns, the well-known indicator of tumor cell dormancy, were 
observed consistently by western blot analysis (Figures S4A,B 
in Supplementary Material). These data suggest a need for fur-
ther investigation as to whether cancer cells acquire a dormant 
phenotype in this model.
However, active cancer cells derived from the mouse cancer 
cell line Pan02 in bone marrow environment showing active 
movement like bone marrow stromal cells were observed very 
rarely and were closely tracked (Figures 1E,F; Videos S7 and S8 
in Supplementary Material). Two-photon intravital imaging of 
cancer cells in calvarial bone marrow also verified that cancer 
cells were in active contact with resident macrophages in the bone 
marrow environment of CX3CR1-GFP mice (Figure 2A; Video 
6Lee et al. Real-Time Cancer Cell Monitoring
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S9 in Supplementary Material). Even after serially sustained 
contact with CX3CR1-GFP or LysM-GFP expressing cells, the 
cancer cells were consistently observed to be viable without 
undergoing immune clearance. Interaction between cancer cells 
and CX3CR1-GFP or LysM-GFP expressing cells were signifi-
cantly decreased 24 h after i.v. injection of cancer cells in both 
LysM-GFP and CX3CR1-GFP mouse, compared to that within 
1 h after i.v. injection of cancer cells (Figure 2B). This difference 
in interactions between cancer cells and stromal cells in the bone 
marrow may result from the fact that temporal change of local 
innate immunity toward cancer cells might be the reason of cancer 
dormancy in the bone marrow environment. Further evaluations 
of this finding should be done to confirm these observations. 
Flow cytometry analysis also revealed that the subpopulation of 
myeloid lineage changed over time after cancer cells entry into 
the bone marrow environment (Figure  2E; Figures S5A,B in 
Supplementary Material).
The effects of chemotherapeutic agents on dormant cancer 
cells in the bone marrow environment are not yet known because 
of the absence of a suitable experimental model. Therefore, an 
interventional experiment was performed using our novel model 
to investigate the impact of a chemotherapeutic agent on cancer 
cells, as well as on the bone marrow environment. After injection of 
the chemotherapeutic agent gemcitabine, the main drug used for 
first or second-line chemotherapy of several solid cancers, such as 
pancreatic cancer, ovarian cancer, lung cancer, and breast cancer, 
we observed that the cell number and movement of various bone 
marrow components were significantly decreased. However, the 
number of cancer cells remained consistent; cancer cells appeared 
to be less affected by the chemotherapeutic agent than other 
normal cells in bone marrow (Figures 2C,D; Videos S10–S12 in 
Supplementary Material). These initial findings from the intravi-
tal imaging model indirectly suggest that current clinical policy 
regarding adjuvant chemotherapy might be creating a paradoxi-
cal effect, in which chemotherapeutic agents induce the relative 
activation of cancer cells in suppressive microenvironments, such 
as cancer cells in the bone marrow environment. A confirmative 
study with a robust experiment design is mandatory to prove these 
initial findings. Another example of an interventional approach 
using our model of the bone marrow environment showed that 
the morphology and movement of immune cells and stromal cells 
in the bone marrow environment were significantly increased 
immediately after i.v. injection of granulocyte-macrophage 
colony factor (GM-CSF). In coculture with murine cancer cell 
lines, active movement and sudden disappearance of the cancer 
cells from bone marrow environment was observed in a small 
portion of the engulfed tumor cells in the perivascular area of the 
mouse bone marrow. Bone marrow stimulation by GM-CSF was 
a significant factor for reactivation of cancer cells in the mouse 
bone marrow environment (Figure 2F). These findings indicate 
that GM-CSF administration due to neutropenia after chemo-
therapy could unintentionally cause the activation of cancer cells 
in the bone marrow environment. Further investigations into the 
detailed mechanisms of this paradoxical phenomenon should be 
performed to address these concerns.
Bone marrow is a representative depot for the distribution of 
cancer cells clinically known as minimal residual disease (18–21). 
Nonetheless, only a few studies on cancer cells in the bone mar-
row environment have shown direct experimental evidence of 
their biology. In this study, we have successfully established two 
imaging models for intravital observation of the bone marrow 
in both the skull calvarium and femur. These intravital imaging 
models can elucidate the detailed biology of cancer cells, including 
their distribution and biological behavior in response to specific 
stimulation as well as reactivation phenomenon. Femur bone 
marrow transplantation from a cancer cell-injected mouse to the 
dorsal area of a healthy mouse was first developed to identify the 
biology of the cancer cells in the bone marrow using two-photon 
intravital microscopy. The combination of the calvarial window 
for observing indigenous healthy bone marrow and the dorsally 
transplanted cancer cell-bearing bone marrow model could cap-
ture the entire process, from the bone marrow dissemination of 
cancer cells to systemic metastasis, as novel experimental animal 
models using intravital imaging. These findings are consistent 
with current theories of cancer cells behavior in the bone marrow 
environment. Additionally, our results verified that even after 
constant exposure to neutrophils and macrophages, the cancer 
cells were robustly viable in the bone marrow environment. This 
phenomenon provides new insights for cancer immunology in the 
bone marrow environment favoring immune tolerance for cancer 
cells. Chemotherapeutic agents caused significant damage to 
in situ bone marrow components but did not influence the viabil-
ity of cancer cells in the bone marrow environment. The presence 
of cancer cells in bone marrow in patients has been strongly sug-
gested to be a risk factor for metastasis (22–24). However, clinical 
implications of cancer cells in bone marrow-targeting strategies 
for preventing metastasis could only be addressed when detailed 
mechanistic analysis of cancer cell biology in bone marrow was 
undertaken in preclinical models (4, 25, 26). It is, therefore, 
inevitable that an in vivo bone marrow cancer cell model should 
be developed for real-time monitoring and tracking (27).
There are several limitations in this study regarding insuf-
ficient experimental validations for specific biologic process and 
limited scope to perivascular niche for the cancer cells in the bone 
marrow environment. Although the experiments of intravital 
imaging were conducted as far as possible from the interface of 
implantation, the method of bone marrow transplantation, which 
can create artificial wound repair-like process, can also affect 
the result of experiments using the femur bone transplantation 
model. The experimental set-up and initial validations, how-
ever, were primary milestone in this study. Therefore, vigorous 
experimental validation and subsequent functional study should 
be followed. Taken together in this study, we showed that the 
specific biologic process of cancer cells in bone marrow can be 
elucidated in high resolution using two-photon intravital imag-
ing. This novel method offers a very useful tool for gaining new 
insights into cancer cell biology in bone marrow, especially, the 
identification of both dormancy and reactivation of cancer cells 
in bone marrow in vivo.
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FigUre s1 | Calvarial bone marrow imaging model. (a) The scalp was removed 
by scissors with a 1.5-cm radius size. (B) Acrylic resin was applied around the 
exposed skull area to attach a fixation ring for the attachment with imaging mount 
module. (c) The fixation ring was attached to the pre-applied acrylic resin and 
then assembled with stereotactic head fixation device attached to a heating plate. 
(D) Two-photon microscopy revealed the typical bone marrow structure of the 
calvarium with trabecular anatomical structures in cortical bone (scale 
bar = 50 µm). (e) The number of viable cancer cells (MCF7) in calvarial bone 
marrow according to the number of injected cancer cells. (F) The number of viable 
cancer cells (MCF7) in calvarial bone marrow according to the period after cancer 
cell injection, from 1 to 28 days (the number of injected cancer cells: 1 × 107).
FigUre s2 | Dorsally transplanted femur bone marrow imaging model. (a) Bone 
graft processing from donor femur bone. (B) Final visualization of dorsal window 
for transplanted femur bone marrow using two-photon microscopy. (c) Operative 
procedures and mounting for intravital imaging of dorsal chamber implantation 
into recipient mouse. Detailed operative procedures are described in Section 
“Materials and Methods.”
FigUre s3 | Human cancer cell lines adapt to bone marrow environment by 
dormant phenotype. (a) Proliferation assay for cancer cells with or without 
coculture to identify the inhibition effect of cancer cell proliferation by bone marrow 
stromal cells. Cancer cells (MIA PaCa-2, AsPC-1, MCF-7, and MDA-MB-231) 
alone or in coculture with NIH/3T3 (mouse fibroblast) cells or mouse bone marrow 
stromal cells that were aspirated from the femur bone of C57BL/6 mice. Coculture 
was performed on a 6-well plate (cancer vs. fibroblast or BM stromal cell = 1:10 
ratio). (B) Relative fluorescence units on culture day 6. Proliferation of cancer cells 
coculture with mouse BM stromal cells compared to NIH/3T3 was significantly 
decreased in MIA PaCa-2 and MCF7 cell lines in the Mann–Whitney U test 
(relative fluorescence unit of MIA PaCa-2 in day 6 relative to day 1; 4.42 ± 1.18 in 
coculture with NIH/3T3 vs. 1.65 ± 0.52 in coculture with mouse BM stromal cells, 
MCF7; 4.47 ± 0.34 in coculture with NIH/3T3 vs. 1.74 ± 0.27 in coculture with 
mouse BM stromal cells, *p < 0.05). Data were averaged from independently 
repeated experiments three times. (c) Microscopy images of each cell line under 
bright field and green fluorescence. Bar graphs represent mean ± SD, scale 
bar = 30 µm. (D) Live cell imaging and (e) quantitative analysis of MCF7 cells 
showed restricted proliferation compared to active proliferation in monoculture 
and coculture with NIH/3T3 cells in the Mann–Whitney U test. *p < 0.05. See 
Videos S10–S12 in Supplementary Material. Representative data were shown 
from independently repeated experiments three times.
FigUre s4 | Western blot analysis of ERK/p-ERK/p38/p-p38 in mouse cancer 
cell line monocultures vs. coculture with mouse bone marrow. (a) Western blot 
to confirm of cancer dormancy at the molecular level. Various cancer cell-lines 
originated from a C57BL6 mouse (MMT060562, LLC, Pan02, SL4) were 
cocultured with mouse bone marrow stromal cells that were aspirated from the 
femur bone of a C57BL6 mouse. Blotting images represent the relative protein 
expressions of p-ERK/ERK and p-p38/p38 in cancer cell-lines. (B) Quantitative 
analysis of western blot images with or without coculture with mouse bone 
marrow by the Mann–Whitney U test. Expression ratio of phospho-ERK with 
phospho-p38 between monoculture and coculture with BM were significantly 
different in MMT060562 and SL4 cell lines. *p < 0.05. The mean values were 
quantified from pooled experiments conducted using different lysates from 
independent samples three times.
FigUre s5 | Temporal changes of myeloid lineage in mouse bone marrow 
after cancer cell injection via tail vein. (a) Chronological flow cytometry analysis 
showing control and 1 and 7 days after cancer cell injection via the tail vein. 
Injectable saline without cancer cells was injected to control mice. The 
acquisition of bone marrow was performed by the aspiration from bone 
marrow of the femur bone at the day of injection (control) and 1 and 7 days 
after injection via the tail vein. (B) Quantitative analysis of temporal changes for 
myeloid derived suppressive factors in myeloid lineage subpopulation MHC 
IIloCD11b+Ly6ChiLy6G−. Relative expression of Arg-1 was significantly increased 
in days 1 and 7 compared to control (relative expression of Arg-1; 1.62 ± 0.73 
in day 1 vs. 2.21 ± 0.48 in day 7, *p < 0.05, ***p < 0.001). The Mann–Whitney 
U test was used to calculate the statistical significance. The mean values were 
quantified from independently repeated experiments three times.
ViDeO s1 | 4D live imaging tracking of dorsally transplanted femur bone graft 
(scale bar = 30 µm).
ViDeO s2 | 3D structural analysis for vascular connections between the donor 
bone marrow and recipient fascia layer.
ViDeO s3 | GFP-expressing monocytes and macrophages (CXCR1-GFP, left 
side movie) and RFP expressing cancer cells (MCF7-RFP, right side movie) in 
bone marrow environment (scale bar = 50 µm, time stamp: hh/mm/ss).
ViDeO s4 | 4D tracking for an active cancer cell (Pan02-RFP) in the bone 
marrow environment (scale bar = 50 µm).
ViDeO s5 | Focused view of 4D tracking for Panc02-RFP cells in the bone 
marrow environment (scale bar = 25 µm).
ViDeO s6 | Active interaction between MCF7-RFP cells and CX3CR1-
GFP positive cells in early phase of cancer cell entry into the bone marrow 
environment (scale bar = 50 µm).
ViDeO s7 | The bone marrow environment 1 h after gemcitabine injection 
intravenously (scale bar = 50 µm).
ViDeO s8 | The bone marrow environment 24 h after gemcitabine injection 
intravenously (scale bar = 50 µm).
ViDeO s9 | The bone marrow environment 144 h after gemcitabine injection 
intravenously (scale bar = 50 µm).
ViDeO s10 | Live cell imaging for monoculture of cancer cells (MCF7-RFP) 
during 36 h in vitro (time stamp: hh/mm/ss, scale bar = 100 µm).
ViDeO s11 | Live cell imaging for cancer cells (MCF7-RFP) coculture with 
NIH/3T3 during 36 h in vitro (time stamp: hh/mm/ss, scale bar = 100 µm).
ViDeO s12 | Live cell imaging for cancer cells (MCF7-RFP) coculture with mouse 
bone marrow cells during 36 h in vitro (time stamp: hh/mm/ss, scale bar = 100 µm).
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